Compliance costs

• FDA scrutiny of WHOOP signals challenges for niche wearable device makers - (Corrects dateline to Dec 3) By Puyaan Singh and Sneha S K Dec 3 (Reuters) - Niche fitness-tracking firms such as WHOOP are coming under increased regulatory scrutiny as technological advances blur